Origin Materials Adds Key New Technical Hires to Further Strengthen Global Technology Leadership in Carbon Negative Materials

Origin Materials Adds Key New Technical Hires to Further Strengthen Global Technology Leadership in Carbon Negative Materials

Highly skilled veterans bring extensive expertise and experience in industrial chemical engineering, petrochemicals, solids processing, refining and renewable energy

WEST SACRAMENTO, Calif.–(BUSINESS WIRE)–Origin Materials, Inc. (“Origin Materials”), the world’s leading carbon negative materials company, today announced the addition of Mr. Jim Wells, Dr. Ben Freireich, and Dr. Madhu Anand to the company’s technical team.

Origin Materials’ new technical hires will play a key role in leveraging the company’s patented, breakthrough carbon negative platform technology to develop and scale new innovations. Origin Materials believes its technology will help revolutionize the production of a wide range of end products, including clothing, textiles, plastics, packaging, car parts, tires, carpeting, toys and more with a ~1 trillion addressable market.

“I am very pleased to welcome these highly skilled veterans to Origin Materials to further bolster our global technology leadership and capabilities in carbon negative materials,” said John Bissell, Co-Founder and Co-CEO of Origin Materials. “Jim, Ben and Madhu bring deep chemical, energy and solids processing experience to Origin Materials and their technical expertise will play a pivotal role in driving our innovation pipeline to deliver carbon negative solutions to our global customer base across a wide range of product end markets.”

Jim Wells joins Origin Materials as a Technical Director with 39 years of experience in the chemical industry. During his 39-year career at The Dow Chemical Company, Mr. Wells was responsible for developing, designing, building, and starting up industrial chemical plants, leading project teams and developing unique technologies. In January 2018, Mr. Wells retired from Dow as Associate Director of Technology for the Dow AgroScience division. He is a recognized subject matter expert in project management, engineering and manufacturing work processes, reactive chemicals and layer of protection analysis, and solids processing, handling and packaging. Mr. Wells served in the United States Army and graduated from Cornell University with a BS in Chemical Engineering.

Ben Freireich joins Origin Materials as a Technical Fellow with more than a decade of experience in the chemical and process industries. Dr. Freireich comes to Origin Materials as a leading industry expert in both product and process research and development for solid materials. Prior to Origin Materials, Dr. Freireich served as the Technical Director of Particulate Solid Research, Inc. (PSRI) where he led applied process research efforts for a consortium of over thirty multinational corporations. He was previously a Research Scientist in Core R&D at The Dow Chemical Company, where he served as subject matter expert responsible for product and process development over a wide range of businesses, products, and technologies. Dr. Freireich is a specialist in particle technology with expertise in particle design, powder flowability, mixing, fluidization, size enlargement, attrition, and other areas of solids engineering, and has authored chapters of Perry’s Chemical Engineering Handbook. He obtained his PhD in Mechanical Engineering from Purdue University studying manufacturing processes involving solid materials. Dr. Freireich also holds a Master of Science in Engineering from Purdue and graduated from the Milwaukee School of Engineering with a BS in Mechanical Engineering.

Madhu Anand joins Origin Materials as a Technical Director with more than 15 years of experience in the oil and energy industry. Prior to Origin Materials, Dr. Anand held various roles at Phillips 66, most recently serving as Chief Engineer of Hydroprocessing & Naphtha Upgrading, where she played a key role in strategy, technology evaluation and development, product management, joint venture management, and commercial development. Dr. Anand is highly skilled at developing technologies and solving complex problems for the refining, renewables, and petrochemical sectors and is recognized for directing scale-up projects from lab to commercial implementation involving multidisciplinary teams. She completed her PhD in Chemical Engineering from Auburn University, where she received the 2007 Outstanding Graduate Award for excellence in research, and graduated from Panjab University in India with a BS in Chemical Engineering.

About Origin Materials

Headquartered in West Sacramento, Origin Materials is the world’s leading carbon negative materials company. Origin Materials’ mission is to enable the world’s transition to sustainable materials. Over the past 10 years, Origin Materials has developed a platform for turning the carbon found in non-food biomass into useful materials, while capturing carbon in the process. Origin Materials’ patented drop-in core technology, economics and carbon impact have been validated by trusted third parties and are supported by a growing list of major global customers and investors. Origin Materials’ first plant is expected to be operational in 2022 with a second, full-scale commercial plant expected to be operational by 2025 and plans for additional expansion over the next decade.

On February 17, 2021, Origin Materials and Artius Acquisition Inc. (“Artius”) (Nasdaq: AACQU, AACQ), a publicly-traded special purpose acquisition company, announced a definitive agreement for a business combination that will result in Origin Materials becoming a public company. Upon closing of the transaction, expected in the second quarter of 2021, the combined company will be named Origin Materials and remain listed on the Nasdaq under the new ticker symbol “ORGN.” The transaction is expected to fully fund Origin Materials until EBITDA positive, and allows Origin Materials to scale and commence commercial production to meet signed customer offtake and capacity reservations of ~$1 billion across a diverse range of industries.

For more information, visit www.originmaterials.com.

Important Information for Investors and Stockholders

In connection with the proposed business combination transaction, Artius filed a registration statement on Form S-4 (the “Registration Statement”) with the SEC on March 9, 2021, which includes a preliminary proxy statement to be distributed to holders of Artius’s ordinary shares in connection with Artius’s solicitation of proxies for the vote by Artius’s stockholders with respect to the proposed transaction and other matters as described in the Registration Statement, as well as the prospectus relating to the offer of securities to be issued to Artius’s and Origin Materials’ stockholders in connection with the proposed transaction. After the Registration Statement has been declared effective, Artius will mail a definitive proxy statement, when available, to its stockholders. Investors and security holders and other interested parties are urged to read the proxy statement/prospectus, any amendments thereto and any other documents filed with the SEC carefully and in their entirety when they become available because they will contain important information about Artius, Origin Materials and the proposed transaction. The documents relating to the proposed transaction (when they are available) can be obtained free of charge from the SEC’s website at www.sec.gov. Free copies of these documents, once available, may also be obtained from Artius by directing a request to: Artius Management LLC, 3 Columbus Circle, Suite 2215 New York, New York 10019.

Cautionary Note on Forward-Looking Statements

This press release contains certain forward-looking statements within the meaning of the federal securities laws, including with respect to the proposed transaction between Origin Materials and Artius. Forward-looking statements generally are accompanied by words such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “should,” “would,” “plan,” “predict,” “potential,” “seem,” “seek,” “future,” “outlook,” and similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding Origin Materials’ business strategy, estimated total addressable market, commercial and operating plans, product development plans and projected financial information. These statements are based on various assumptions, whether or not identified in this press release, and on the current expectations of the management of Origin Materials and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on as, a guarantee, an assurance, a prediction, or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of Origin Materials and Artius. These forward-looking statements are subject to a number of risks and uncertainties, including that Origin Materials may be unable to successfully commercialize its products; the effects of competition on Origin Materials’ business; the uncertainty of the projected financial information with respect to Origin Materials; disruptions and other impacts to Origin Materials’ business as a result of the COVID-19 pandemic and other global health or economic crises; changes in customer demand; Origin Materials and Artius may be unable to successfully or timely consummate the proposed business combination, including the risk that any regulatory approvals may not obtained, may be delayed or may be subject to unanticipated conditions that could adversely affect the combined company or the expected benefits of the business combination, or that the approval of the stockholders of Artius or Origin Materials may not be obtained; failure to realize the anticipated benefits of the business combination; the amount of redemption requests made by Artius’ stockholders, and those factors discussed in the Registration Statement under the heading “Risk Factors,” and other documents Artius has filed, or will file, with the SEC. If any of these risks materialize or our assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that Origin Materials presently does not know, or that Origin Materials currently believes are immaterial, that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect Origin Materials’ expectations, plans, or forecasts of future events and views as of the date of this press release. Origin Materials anticipates that subsequent events and developments will cause its assessments to change. However, while Origin Materials may elect to update these forward-looking statements at some point in the future, Origin Materials specifically disclaim any obligation to do so. These forward-looking statements should not be relied upon as representing Origin Materials’ assessments of any date subsequent to the date of this press release. Accordingly, undue reliance should not be placed upon the forward-looking statements.

Participants in the Solicitation

Artius, Origin Materials and their respective directors, executive officers and employees and other persons may be deemed to be participants in the solicitation of proxies from Artius’s shareholders in connection with the proposed business combination. Information about Artius’s directors and executive officers and their ownership of Artius’s securities is set forth in the Registration Statement described above. Additional information regarding the interests of those persons and other persons who may be deemed participants in the proposed transaction may be obtained by reading other documents Artius has filed, or will file, with the SEC regarding the proposed business combination, including the definitive proxy statement when it becomes available.

Non-Solicitation

This communication is not a proxy statement or solicitation of a proxy, consent or authorization with respect to any securities or in respect of the potential transaction and shall not constitute an offer to sell or a solicitation of an offer to buy the securities of Artius, the combined company or Origin Materials, nor shall there be any sale of any such securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of the Securities Act of 1933, as amended.

Investors:

[email protected]

Media:

[email protected]

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Chemicals/Plastics Other Energy Environment Manufacturing Alternative Energy Energy Other Manufacturing

MEDIA:

Boston Private Files Investor Presentation and Board of Directors Sends Letter to Shareholders Regarding the Proposed Transaction with SVB Financial

Boston Private Files Investor Presentation and Board of Directors Sends Letter to Shareholders Regarding the Proposed Transaction with SVB Financial

The SVB Financial Merger Continues To Be Financially and Strategically Compelling

HoldCo’s Proposal Is Reckless, Founded on Flawed Valuation Analyses and Misleading Assertions, and Value Destructive

BOSTON–(BUSINESS WIRE)–
The Board of Directors of Boston Private Financial Holdings, Inc. (NASDAQ: BPFH) (“Boston Private”), a leading provider of integrated wealth management, trust and banking services to individuals, families, businesses and nonprofits, today issued an investor presentation and sent a letter to Boston Private’s shareholders regarding the previously announced definitive merger agreement with SVB Financial Group (NASDAQ: SIVB) (“SVB Financial”). The investor presentation is available at https://ir.bostonprivate.com/files/doc_presentations/2021/04/Investor-Presentation.pdf.

The letter and investor presentation reiterate why the SVB Financial transaction continues to provide the best path for maximizing value for Boston Private shareholders, and respond in detail to HoldCo’s misleading assertions, unsubstantiated analyses and reckless and illusory proposal that threatens to destroy substantial shareholder value.

The Boston Private Board unanimously recommends that shareholders vote on the WHITE proxy card “FOR” the proposed transaction with SVB Financial and “FOR” the other matters to be considered at the April 27, 2021 special meeting.

The full text of the letter from the Board of Directors to shareholders follows.

April 7, 2021

 

Dear Boston Private Shareholders:

 

The special meeting of Boston Private shareholders to approve the value-maximizing transaction with SVB Financial, scheduled for April 27, 2021, is rapidly approaching. 

 

If the merger with SVB Financial is completed, holders will be entitled to receive, for each share of Boston Private common stock owned, $2.10 in cash and 0.0228 shares of SVB Financial common stock, an implied value of $13.12 per share of Boston Private common stock based on the closing stock price of SVB Financial common stock on April 1, 2021, representing a 56% premium to Boston Private’s unaffected share price as of immediately prior to announcement of the transaction.

 

The Boston Private Board of Directors (the “Board”) carefully considered the company’s available alternatives and concluded that the transaction maximizes value for, and is in the best interests of, all Boston Private Shareholders.  The Board unanimously recommends that you vote on the WHITE proxy card “FOR” the proposed transaction with SVB Financial and “FOR” the other matters to be considered at the April 27, 2021 special meeting to approve the transaction.  You can vote by mail, over the Internet or by a toll-free telephone call.  Simply follow the instructions on the attached WHITE proxy card.  We urge you to vote by telephone or over the Internet to ensure your vote is received in time to be counted at the special meeting. 

 

Your vote is very important, regardless of how many shares you own.  The failure to vote your shares or an abstention from voting has the same effect as a vote against the transaction.  The transaction cannot be completed unless the merger agreement is approved by the affirmative vote of at least 66 2/3% of the outstanding shares of Boston Private common stock entitled to vote.

 

You may have received communications from an entity called HoldCo Asset Management, LP (“HoldCo”) seeking your support to defeat the transaction with SVB Financial.  The Board believes that HoldCo’s illusory proposal is a reckless gamble based on arguments without merit that, if successful, would imperil the value of your investment in Boston Private.  

 

Your Board is unanimous in its opposition to HoldCo’s efforts and recommends you ignore their communications and not vote any of their gold proxy cards.  If you have voted on a gold proxy card, please vote FOR the proposed transaction with SVB Financial using a WHITE proxy card.  Only your latest dated vote counts. 

 

THE TRANSACTION MAXIMIZES VALUE FOR BOSTON PRIVATE SHAREHOLDERS

 

The Board believes that the transaction with SVB Financial is a financially and strategically compelling opportunity that maximizes value for, and is in the best interests of, all Boston Private shareholders.

 

Compelling Valuation  

 

Across multiple financial metrics, the merger with SVB Financial represents one of the most financially attractive bank deals in years.

 

As a result of the Board’s negotiating efforts, SVB Financial increased the value of the merger consideration offered from $7.60 per Boston Private share in August 2020 to $10.94 per Boston Private share as of December 31, 2020, the last trading day prior to the date of announcement of the merger agreement.  At the time the transaction was announced, the merger consideration represented the highest price to forward earnings-per-share multiple and second-highest announcement date premium in a major bank transaction in the past three years.1  This already-compelling premium has substantially increased since that time as a result of the appreciation of SVB Financial’s share price, and represents an implied value of $13.12 based on SVB Financial’s closing price on April 1, 2021, corresponding to a 56% premium to Boston Private’s unaffected share price as of immediately prior to announcement of the transaction and a 21.2x price to forward earnings-per-share multiple.2  The Board believes that the transaction with SVB Financial provides substantially higher and more certain value to Boston Private shareholders than the company’s available alternatives.      

 

The Right Partnership 

 

SVB Financial is the right partner for Boston Private, which will further benefit current Boston Private shareholders once the merger is completed.  It has a differentiated platform with a long track record of stellar execution and industry-leading growth, all of which will be enhanced by the capabilities of the combined company to leverage SVB Financial’s balance sheet, expansive client network and position at the center of the innovation economy to augment Boston Private’s wealth management solutions and accelerate value creation opportunities for Boston Private shareholders.  Not only does the merger with SVB Financial provide significant immediate financial benefits to Boston Private shareholders through a compelling premium, the Boston Private Board believes that the transaction will enable shareholders to benefit from the strategic merits of the combination by participating in the upside potential of the combined company, and is the clear long-term value maximizing alternative for shareholders.      

 

The Right Timing 

 

The Board’s decision to capitalize on a compelling strategic opportunity with SVB Financial and lock-in a fixed exchange ratio when it did has already generated hundreds of millions of dollars in incremental value for Boston Private shareholders above and beyond the almost 30% premium already embedded in the implied value of the merger consideration at the time of announcement of the transaction.  As described in detail below, delaying negotiations with SVB Financial in order to pursue discussions with other potential counterparties, as HoldCo has proposed, would have wiped away hundreds of millions of dollars in value for Boston Private shareholders, while providing no discernible benefits and significantly increasing various risks, including the potential loss of the SVB Financial deal altogether.  The timing of the transaction was critical to capturing the upside potential in the price of SVB Financial common stock based on SVB Financial’s continued strong performance.       

 

The Right Process

 

Independent Board Conducted Extensive Analysis and Carefully Considered All Available Alternatives

 

In 11 meetings over the course of several months, the Board assessed the company’s standalone plan and the opportunities, risks and challenges associated with that plan, and analyzed with its financial advisor the universe of alternative potential strategic merger partners and the several inbound inquiries it received.  The Board was very familiar with the strategic merits of those potential partners as well as the merger consideration they would potentially be able to offer as the result of the Board’s and its’ advisors’ significant corporate advisory, banking and financial services experience, and deep industry knowledge.  Accordingly, the Board determined that:

  • no potential merger partner would be a better strategic fit or offer more favorable terms or stronger prospects for future growth and value creation to Boston Private shareholders than SVB Financial; and
  • the transaction with SVB Financial would provide more value, sooner, with significantly more certainty and significantly less execution risk, than the company’s standalone plan, while at the same time offering participation in the long-term growth potential of the combined company at a level that was unlikely to be achieved under the standalone plan.

The Board’s Process Maximized Value Without the Risks Inherent in an Auction

 

HoldCo repeatedly asserts that the company referred to in Boston Private’s definitive proxy statement as Company A “was offering a higher price than SVB was offering at that time.”  This is simply false.  Neither Company A nor any other party — other than SVB Financial — made any offer or proposal to acquire Boston Private, either during the negotiation process with SVB Financial or at any time since announcement of the transaction.  HoldCo’s distortions underscore its inability to engage with real-world facts.  Having no on-the-ground experience with bank M&A processes, HoldCo subscribes to a black-and-white, purely theoretical philosophy by which auctions must automatically lead to the best outcome for shareholders.  But the transaction process implemented by the Board was not an academic exercise undertaken in an ivory tower — it was a real-world negotiation carefully designed and calibrated with the advice of expert advisors to maximize value for Boston Private shareholders.  In the real-world, the tone of a conversation matters, timing matters and reasoned and experienced assessments of a potential acquiror’s preparation, seriousness and ability to pay matter. 

 

These nuances are lost on HoldCo, but they are reflected in precedent bank transactions, where a majority of target companies do not undertake auction processes, and where auction processes generally do not produce better results than bilateral negotiations.3  The reasons are simple:  the universe of potential strategic buyers for banks of Boston Private’s size is limited and well-known to those in the industry; to the extent that any such potential buyers are interested in a strategic combination, they typically make their interest known to targets proactively; and for a business whose principal assets — its people — walk out the door at the end of every business day, the risks of running a broad auction process and exposing the company to potential leaks, market rumors and resulting employee and customer attrition are real and need to be weighed against the hypothetical and, in many cases, illusory benefits of running such a process.   

 

Yet HoldCo would apparently have Boston Private open up its books and provide highly confidential and competitively sensitive diligence materials and access to employee and customer information to any competitor that expresses even the slightest interest in discussing a possible transaction, no matter how vague, soft or flimsy their overtures or terms might be.  The Board disagrees with that philosophy. 

 

A review of the inquiries from HoldCo’s three purported potential buyers confirms that there was no credible reason for Boston Private to affirmatively pursue further discussions with any of these parties, and that the Board chose the value-maximizing process.  

 
  • Company A:  Notwithstanding HoldCo’s mischaracterizations, Company A never made any proposal to acquire Boston Private.  Instead, it approached Boston Private casually based on speculation that Boston Private might already be considering a strategic business combination and indicated that, subject to numerous contingencies, it might consider a valuation at a tangible book value multiple in a general price range of $10.50.  Company A never submitted any letter, indication of interest or other written expression of interest, nor did it propose any specific transaction terms, or indicate whether an actual proposal was expected to be discussed with or approved by its board of directors.  The Board discussed and considered Company A’s outreach and determined that it was highly speculative and contingent.  The Board also concluded that there was greater upside potential in SVB Financial’s stock price, and therefore in the value of the merger consideration, that would not apply to Company A even if it were to submit an actionable proposal at or around its indicated potential valuation level.  After considering all the facts, the Board concluded that Company A was unlikely to (i) be a better strategic fit for Boston Private than SVB Financial, (ii) offer terms more favorable to Boston Private’s shareholders than those offered by SVB Financial, or (iii) offer better prospects for future growth and value accretion for the benefit of Boston Private’s shareholders.
  • September 2020 Inquiry:  HoldCo criticizes Boston Private for not inviting another party that inquired about a transaction in September 2020 to participate in an auction process.  As previously disclosed, this party inquired about a transaction at a 20-25% premium to Boston Private’s then-current stock price, which was in the range of $5.50 per share, implying a transaction value of around $6.60 – $6.87 per share.  At that time, discussions with SVB Financial centered around SVB Financial making a proposal valuing Boston Private at approximately $9.25 per share, which the Boston Private Board concluded was still an inadequate price.  There was simply no reason for Boston Private to waste time, money and effort, or magnify the attendant confidentiality, competitive, employee and customer retention risks, by engaging on an inquiry with such an inferior value proposition.
  • Similarly-Sized California-Based Bank Holding Company:  Finally, HoldCo suggests that Boston Private should have engaged in transaction negotiations with a California-based bank holding company of similar size to Boston Private.  As previously disclosed, in 2019 Boston Private engaged in preliminary discussions with representatives of this potential counterparty, which centered around an acquisition by Boston Private of this counterparty — a completely different transaction than the SVB Financial merger (or, for that matter, any sale transaction advocated by HoldCo), in which Boston Private would be paying a premium, instead of receiving one.  Boston Private had previously determined that such a transaction would not be financially attractive or create meaningful value for Boston Private shareholders, and that this company was not a strong financial, cultural or strategic fit for Boston Private.  Accordingly, there was no reason to engage in further discussions with this potential counterparty.  HoldCo’s contention that inviting this party — whose apparent interest was in being acquired by Boston Private — to participate in an auction to acquire Boston Private would have somehow generated competitive pressure and resulted in SVB Financial delivering additional merger consideration defies logic, and further underscores HoldCo’s lack of understanding of real-world negotiating dynamics.

Far from lending support to HoldCo’s auction theory, what these various informal inquiries actually show is that the Board was extremely well-informed regarding the pool of potential strategic counterparties that might be interested in pursuing a strategic combination and the level of consideration that they might be able and willing to offer.  If any of the parties that HoldCo asserts would have offered superior financial terms, or indeed any other potential strategic partner, were in fact interested in and capable of acquiring Boston Private at a premium valuation relative to the merger with SVB Financial, they would have submitted a proposal.  None did.

 

Contrary to HoldCo’s monolithic view of M&A processes, the Board does not believe that there is any single blueprint for how to achieve the best result in selling a company.  It is a fact- and context-specific determination that requires careful consideration and evaluation of a number of factors that bear on the risks and benefits of approaching additional parties or instead pursuing a transaction with a company that has made a compelling strategic offer.  The Board ran a robust, thorough and value-maximizing process for Boston Private shareholders and successfully secured one of the highest premia of any bank merger in years, and locked-in an exchange ratio at a time that has allowed Boston Private shareholders to benefit from the substantial upside in SVB Financial’s stock price. 

 

HOLDCO’S PATH FORWARD IS RECKLESS, NOT VIABLE AND EXPOSES BOSTON PRIVATE SHAREHOLDERS TO SIGNIFICANT RISKS

 

While the Board has provided a value-maximizing transaction with a compelling premium and significant long-term upside prospects, HoldCo lacks any coherent strategy or viable value proposition for Boston Private shareholders, and its proposed “path forward” is illusory and would expose you to major risks.

 

It is clear that prior to the announcement of the SVB transaction, HoldCo was planning to launch a proxy fight against the Board and advocate for a sale of the company.  But before HoldCo could do so, the Board capitalized on the opportunity with SVB Financial, delivering a strategic transaction at a price that maximizes value for Boston Private shareholders.  The Board preempted HoldCo’s platform by doing what was right for Boston Private shareholders and acting at the right time, but HoldCo is determined to move forward with its contest anyway.

 

The result is a “path forward” that is reckless, unrealistic and lacks any feasible means of delivering additional value.  Notwithstanding HoldCo’s claims that the steps to achieving enhanced value are “simple and straightforward,” they are in fact fraught with risk.     

 

HoldCo’s Proposed Sale Process Threatens To Expose Boston Private to Uncapped Damages

 

HoldCo continues to propose that Boston Private “commence a competitive [sale] process immediately.”  But as the Board noted in its prior communication to shareholders, commencing such a process would be a willful breach of Boston Private’s obligations under the merger agreement with SVB Financial, an inconvenient fact that HoldCo knows, or should know if it had in fact read the publicly available merger agreement, but has blatantly ignored in all of its communications to you.  HoldCo is either attempting to deliberately mislead you or is willing to expose your company to uncapped potential damages. 

 

HoldCo’s proposed path forward is a fantasy, and entirely illusory.  Unless the parties mutually agree to terminate the merger agreement, until the January 3, 2022 termination date is reached or another termination event occurs, neither party can abandon the transaction and each must use reasonable best efforts to complete the merger.

 

HoldCo’s Expectations of Potential Acquirors Are Unrealistic and Unsupported

 

HoldCo has now implicitlyacknowledged that a previously unknown mystery acquiror is not likely to materialize.  As such, HoldCo is pinning its hopes on a limited universe of potential acquirors, several of whom made informal and preliminary inquiries of Boston Private that the Board carefully evaluated and, as discussed above, determined (correctly) were unlikely to result in terms more favorable to Boston Private shareholders than those offered by SVB Financial.  HoldCo has not demonstrated why any of those parties, or for that matter any other potential acquiror, would suddenly be likely to make a proposal to acquire Boston Private, much less one that delivers more value than the transaction with SVB Financial.  To date, no such proposal has been made.  HoldCo may be comfortable taking a flyer on the unlikely possibility of such a proposal emerging; the Board is not.       

 

Proposed Slash and Burn Approach Would Destroy Value

 

Perhaps understanding that re-initiating a sales process is not feasible and that there is no mystery acquiror waiting in the wings, HoldCo has pivoted to proposing vague operational changes that amount to nothing more than a slash and burn approach designed to artificially boost short-term share price performance through excessive cost cutting and return of capital, to the detriment of the long-term value of the Boston Private franchise.  HoldCo’s analysis, resting on faulty and unsubstantiated assumptions, would fail to deliver value to Boston Private shareholders on par with the SVB Financial merger consideration even in the short term and likely result in significant customer and employee attrition and irredeemable damage to the Boston Private business.  To make its plan appear to create value, HoldCo makes a series of groundless assumptions, including establishing cost-savings by reference to a set of peers with very different business models, assuming multiple expansion solely as a result of cost-cutting, and, most egregiously, assuming that the company could buy back $115 million of its shares at $10 while bumping its share price to more than $17 — an assumption both absurd on its face and that would raise serious questions under the federal securities laws. 

 

HoldCo’s standalone “plan,” which might as well have been sketched out on the back of a napkin, further illustrates the dangers of delegating the strategy for ongoing operations of Boston Private and its subsidiaries to HoldCo.  This slash and burn approach that fails to deliver value in the short term while destroying Boston Private’s long-term prospects stands in stark contrast to the compelling value, upside participation and certainty of execution that the SVB Financial transaction will deliver for Boston Private shareholders.

 

HoldCo’s Withdrawal of Its Own Nominees Demonstrates a Lack of Commitment and the Absence of a Coherent Strategy

 

As the Board previously noted, HoldCo was forced to withdraw its nomination notice with respect to two of its nominees to the Boston Private Board — HoldCo’s own co-founders Michael Zaitzeff and Vikaran Ghei — due to its parallel threatened proxy fight against another Boston-based bank holding company, Berkshire Hills Bancorp, Inc., where it also nominated Mr. Zaitzeff to the board of directors.  That HoldCo consciously decided to forego the possibility of nominating a majority slate that included HoldCo’s founders to the Boston Private Board in favor of having a single representative on the Berkshire board demonstrates HoldCo’s utter lack of conviction in the strength of its arguments or its likelihood of success.  Moreover, it confirms that HoldCo does not have a coherent strategy.  It has a bag of risky, half-baked proposals and no idea how to execute on them.  Even if HoldCo’s three unaffiliated nominees were elected to the Board and adopted HoldCo’s agenda, they would constitute only a minority of the Board and would have no mechanism to cause Boston Private to pursue HoldCo’s ill-advised and risky gambles, and given HoldCo’s board seat at Berkshire Hills, a competing bank operating in the same market as Boston Private, it is far from clear that HoldCo would even be able to actively participate, directly or indirectly, in key strategic decisions of the Boston Private Board given antitrust, bank regulatory and confidentiality considerations. 

 

Though HoldCo has not articulated a feasible “path forward,” all of its proposed roads lead to the same dead end:  giving up a compelling transaction with certainty of value and significant upside in favor of a collection of reckless gambles, each with substantial and readily apparent risks, and highly theoretical and illusory potential benefits. 

 

HOLDCO’S MISGUIDED ATTACKS AND BASELESS ASSUMPTIONS ARE NO SUBSTITUTE FOR THE BOARD’S INFORMED VALUATION ANALYSES

 

In considering the SVB Financial transaction, the Board and its advisors carefully evaluated Boston Private’s standalone plan and the valuation it implied, and determined that the SVB Financial transaction would deliver more value, sooner, with significantly more certainty and significantly less execution risk than the company’s standalone plan.  

 

In contrast, Holdco has not undertaken any serious valuation analyses or engagement with Boston Private’s standalone plan, and has made no attempt to defend its naive “sum of the parts” and “contribution” analyses — methodologies that are inapplicable to Boston Private’s business or the transaction at hand, include numerous flawed assumptions and ignore fundamental valuation principles.  Instead of defending its analyses, HoldCo has resorted to attacking the market’s valuation of SVB Financial, using sleights of hand and pretending the world did not change as a result of the pandemic. 

 

Attacks Against SVB Financial Are Misguided

 

HoldCo presents several purported analyses that, while framed in different ways, boil down to a single assertion:  HoldCo believes that the market is ascribing too much value to SVB Financial’s shares, and that it knows better than the market.   

 

HoldCo’s attacks against SVB Financial have no basis in reality.  As industry analysts recognize, SVB Financial has a differentiated platform with exceptional growth opportunities in key industries, along with a history of operational excellence and credit quality that leaves little doubt about its ability to successfully capitalize on these opportunities.  SVB Financial’s premium valuation is not a short-term blip — it is based on a long-term track record of successful execution:  over the last ten years, SVB Financial has significantly outperformed its peers on almost every key metric.  Accordingly, each of SVB Financial’s 1-, 3-, 5- and 10-year total shareholder returns far outpace its peers and banks generally.4 The market again validated SVB Financial’s premium valuation just two weeks ago, as SVB Financial successfully raised $1 billion in a common stock offering from major institutional investors in a single day at a price of $500 per share, implying a price-to-earnings multiple of 24.4x.5

 

HoldCo’s attacks on SVB Financial fly in the face of what the rest of the market already knows, has known for years and has very recently validated — that SVB Financial’s unique position at the center of the innovation economy, fundamentally different balance sheet and earnings growth opportunities and outstanding record of performance justify its premium multiple.

 

HoldCo Is Living in a Pre-Pandemic World   

 

HoldCo attempts to undermine the compelling value created by the SVB Financial transaction by comparing the value of the merger consideration to Boston Private’s pre-pandemic share price and referencing the parties’ pre-pandemic performance.  These comparisons are irrelevant, out of touch with reality and fail to take into account the significant changes in interest rates, the competitive environment and the businesses and growth prospects of Boston Private, SVB Financial and their respective clients arising out of the pandemic and ongoing recovery.  HoldCo is living in the past and focused on pre-pandemic performance and share prices.  The Board, on the other hand, is focused on maximizing value for Boston Private shareholders in the present and over the long-term — the Board evaluated Boston Private’s future prospects in light of a changing environment and determined that the transaction with SVB Financial was the best way to maximize value.

 

Sleights of Hand Reinforce HoldCo’s Mistakes

 

HoldCo’s attempt to reframe the transaction consideration in terms of exchange ratio rather than value is not only incorrect, it repeats the same mistakes that HoldCo made in its valuation analyses and highlights how a process managed by HoldCo would have produced inferior results.  HoldCo’s assertions that the Board “ineptly negotiated for lower consideration as the process with SVB unfolded” and that SVB Financial’s final offer represented a 22% decline in value are blatantly false.  The Board negotiated to increase the value of the merger consideration from approximately $7.60 per Boston Private share to $10.94 per Boston Private share at the date of announcement of the transaction, a value reflecting the second-highest premium in a major bank transaction in the last three years.  HoldCo’s attempted sleight of hand again ignores the differing valuation and growth profiles of Boston Private and SVB Financial and the resulting possibility that their share prices would change at differing rates over time, while naively assuming that SVB Financial (or any other potential acquiror) would intentionally undervalue itself by negotiating a transaction without regard for positive changes to its own valuation and growth prospects. 

 

And yet, the increase in SVB Financial’s stock price, the very issue about which HoldCo complains, would have been greatly exacerbated by HoldCo’s suggestion that Boston Private invite other parties into an auction process to somehow “keep SVB honest” about the market value of SVB Financial’s shares.  As HoldCo would have it, Boston Private would have been mired in an auction process with bidders the Board deemed unlikely to be competitive and, as a result, would have missed its window to capture the potential appreciation in the value of SVB Financial shares for the benefit of Boston Private shareholders.  Had Boston Private sought to prolong negotiations with SVB Financial in order to run an auction process, not only would Boston Private have risked losing the SVB Financial transaction altogether, particularly in light of SVB Financial’s final proposal being expressly conditioned on exclusivity, but even if a transaction had materialized based on the ultimately agreed pricing it would have cost Boston Private shareholders approximately $240 million in aggregate consideration value.6  It was precisely those risks, along with the significant risks to the Boston Private franchise from a confidentiality, competitive, and employee and customer retention perspective, that the Board carefully weighed against the potential benefits of rejecting or attempting to delay SVB Financial’s final proposal and pursuing discussions with other potential strategic parties.  The Board correctly concluded that those risks far outweighed any conceivable benefits of delay.  

 

THE BOARD RAN AN EXEMPLARY PROCESS DELIBERATELY SEQUENCED TO AVOID POTENTIAL CONFLICTS

 

The Board’s thoughtful sequencing of the negotiations with SVB Financial avoided conflicts to ensure a result that maximized value for Boston Private shareholders.  HoldCo’s continued efforts to falsely paint the transaction with SVB Financial as a conflict-ridden, management-friendly deal have no basis in fact, do not hold up to even the most cursory level of scrutiny, and are a desperate attempt to gain traction where all substantive arguments have failed.

 

The Board Ran a Model Process

 

The Board ran a thorough, independent-director-driven process that was deliberately sequenced to ensure that any negotiations between Mr. DeChellis or other members of management and SVB Financial related to post-closing employment or retention arrangements occurred only after negotiations regarding the amount of the merger consideration and the other material transaction terms had been finalized.  All members of the Boston Private Board other than Mr. DeChellis are fully independent, and the Board is comprised of a sophisticated and diverse group of directors with decades of collective financial services experience.  Negotiations were led by a working group comprised of Mr. DeChellis and two independent directors with deep M&A and transactional experience.  The Board’s independent Chair, Stephen Waters, was intimately involved in the key pricing negotiations with SVB Financial, all of which took place more than a month before SVB Financial first provided a term sheet to Mr. DeChellis outlining the proposed terms for his continued employment following completion of the merger.  And the entire Board was fully involved in overseeing the transaction process from start to finish. 

 

For the Board to have formed a special committee to negotiate the transaction, as suggested by HoldCo, would have been both unusual and value destructive.  Special committees are extremely rare — they have been used by target boards in just 6% of major bank transactions over the past ten years7 — and are appropriate where there is a true board conflict that cannot otherwise effectively be mitigated, such as a transaction in which a controlling shareholder stands on both sides of a deal or conflicted directors have a special material interest in the transaction.  That was definitively not the case with respect to Boston Private’s arm’s-length, third party merger negotiations with SVB Financial.  Given the sequencing of the negotiations and the composition of the working group, the formation of a special committee would have done nothing to mitigate any purported “conflict.”  Instead, it would have deprived Boston Private of Mr. DeChellis’s operational expertise during negotiations, which was crucial in demonstrating the value of the company and its wealth management franchise to SVB Financial.  A transaction of the strategic importance of the SVB Financial merger demands the careful review and consideration of all directors and should, in the Board’s view, remain squarely within the ultimate province of the full Board, which is exactly what occurred.

 

Further, HoldCo’s contention that the prospect of continued post-closing employment for Mr. DeChellis represented an “irreconcilable conflict of interest” is based on the false premise that Mr. DeChellis was likely to receive better post-closing employment terms from SVB Financial than from any other potential buyer.  HoldCo’s misleading characterizations rely on stale information, make apples-to-oranges comparisons of target to actual compensation levels, and fail to acknowledge Mr. DeChellis’s waiver of termination protections and forfeiture of Boston Private equity awards. The fact is, Mr. DeChellis received from SVB Financial post-closing employment arrangements on customary and reasonable terms, in a strategic transaction where his ongoing involvement in Boston Private’s wealth management business is an important value driver. 

 

Those arrangements are not unique to the SVB Financial transaction — every other hypothetical acquiror cited by HoldCo would have also acquired Boston Private in a strategic transaction where Boston Private’s wealth management business would have been an important value driver, and so would have wanted to hire Mr. DeChellis.  In fact, as disclosed in Boston Private’s definitive proxy statement, in September 2020, one such potential party had expressed interest in hiring away Mr. DeChellis to run its wealth management business apart from an acquisition, which Mr. DeChellis declined.  Mr. DeChellis had no reason to believe that the package offered by SVB Financial would be any better than that offered by any other possible merger partner, and therefore would have had no reason to direct the transaction toward SVB Financial instead of another merger partner.  HoldCo’s contention that there was an “irreconcilable conflict of interest” is wrong, and the Board carefully designed a process to ensure that no such conflict could arise.      

HoldCo’s Assertions Regarding Retention Arrangements Are False

 

In an even more brazen attempt to mislead you, HoldCo falsely asserts that the one-time merger costs expected to be incurred by SVB Financial “represent a direct transfer of wealth from BPFH shareholders to BPFH executives.”  In reality, SVB Financial has offered BPFH executives customary (and for a transaction of this size, relatively modest) retention awards with aggregate value of up to $7.5 million, roughly 3.5% of SVB Financial’s total assumed restructuring costs and undoubtedly similar to what any other acquiror of Boston Private would have offered to ensure continued performance of Boston Private’s franchise.  These retention arrangements were put in place only after the merger was announced and the pricing and other transaction terms were agreed, and are appropriately structured for retentive purposes — executives will not receive their full retention amounts unless they remain employed with SVB Financial for a full four years after completion of the merger. 

 

Most importantly, there is no basis for HoldCo’s assertion that these retention costs, or for that matter any restructuring charges to be incurred by SVB Financial in connection with the transaction, somehow reduced the amount of the merger consideration payable to Boston Private shareholders, which was negotiated more than a month before SVB Financial put any retention arrangements in place or finalized its due diligence and preliminary restructuring cost analysis.   

 

*****

In sum, the Board believes that the transaction with SVB Financial is a financially and strategically compelling opportunity and is the value-maximizing alternative for all Boston Private shareholders.  In contrast, HoldCo’s proposed path forward is an ever-changing assortment of reckless gambles based upon an indefensible valuation and supported only by misleading assertions and unsubstantiated attacks.  The Board believes that betting the future of Boston Private on HoldCo’s illusory proposal is a risk that is simply too grave to tolerate.   

 

For these reasons, and the reasons set out in greater detail in Boston Private’s definitive proxy statement mailed to shareholders and its other materials filed with the SEC, the Board unanimously recommends that you vote on the WHITE proxy card “FOR” the proposed transaction with SVB Financial and “FOR” the other matters to be considered at the special meeting. 

 

Your vote is very important, regardless of how many shares you own.  The failure to vote your shares or an abstention from voting has the same effect as a vote against the transaction.  The transaction cannot be completed unless the merger agreement is approved by the affirmative vote of at least 66 2/3% of the outstanding shares of Boston Private common stock entitled to vote.

 

If you have any questions or need assistance voting your shares, please contact Innisfree M&A Incorporated, Boston Private’s proxy solicitor, by calling toll-free at (877) 800-5187, or for banks and brokers, collect at (212) 750-5833.

 

On behalf of the Boston Private Board, thank you for your continued support of Boston Private.

 

Sincerely,

 

The Boston Private Board

About Boston Private

Boston Private is a leading provider of integrated wealth management, trust and banking services to individuals, families, businesses and nonprofits. For more than 30 years, Boston Private has delivered comprehensive advice coupled with deep technical expertise to help clients simplify their lives and achieve their goals. The firm offers the capabilities of a large institution with the superior service of a boutique firm to clients across the United States. Boston Private is the corporate brand of Boston Private Financial Holdings, Inc. (NASDAQ: BPFH). For more information, visit www.bostonprivate.com.

Advisors

Wachtell, Lipton, Rosen & Katz is serving as legal counsel to Boston Private and Morgan Stanley & Co. LLC is acting as financial advisor to Boston Private.

Forward-Looking Statements

This communication contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including but not limited to SVB Financial’s and/or Boston Private’s expectations or predictions of future financial or business performance or conditions. Forward-looking statements are typically identified by words such as “believe,” “expect,” “anticipate,” “intend,” “target,” “estimate,” “continue,” “positions,” “prospects” or “potential,” by future conditional verbs such as “will,” “would,” “should,” “could” or “may,” or by variations of such words or by similar expressions. These forward-looking statements are subject to numerous assumptions, risks and uncertainties, which change over time. Forward-looking statements speak only as of the date they are made, and we assume no duty to update forward-looking statements. Actual results may differ materially from current projections. In addition to factors previously disclosed in SVB Financial’s and Boston Private’s reports filed with the U.S. Securities and Exchange Commission (the “SEC”), the following factors, among others, could cause actual results to differ materially from forward-looking statements or historical performance: ability to obtain regulatory approvals and meet other closing conditions to the merger, including approval by Boston Private’s shareholders on the expected terms and schedule; delay in closing the merger; the outcome of any legal proceedings that have been or may be instituted against SVB Financial or Boston Private; the occurrence of any event, change or other circumstance that could give rise to the right of one or both parties to terminate the merger agreement providing for the merger; difficulties and delays in integrating Boston Private’s business or fully realizing cost savings and other benefits; business disruption following the merger; changes in asset quality and credit risk; the inability to sustain revenue and earnings growth; the inability to retain existing Boston Private clients; the inability to retain Boston Private employees; changes in interest rates and capital markets; inflation; customer borrowing, repayment, investment and deposit practices; customer disintermediation; the introduction, withdrawal, success and timing of business initiatives; competitive conditions; the inability to realize cost savings or revenues or to implement integration plans and other consequences associated with mergers, acquisitions and divestitures; economic conditions; the impact, extent and timing of technological changes, capital management activities, and other actions of the Federal Reserve Board and legislative and regulatory actions and reforms; and the impact of the global COVID-19 pandemic on SVB Financial’s and/or Boston Private’s businesses, the ability to complete the proposed merger and/or any of the other foregoing risks. Annualized, pro forma, projected and estimated numbers are used for illustrative purpose only, are not forecasts and may not reflect actual results.

Important Additional Information and Where to Find It

In connection with the proposed merger, SVB Financial has filed with the SEC a registration statement on Form S-4 that includes the proxy statement of Boston Private and a prospectus of SVB Financial. The registration statement on Form S-4, as amended, was declared effective by the SEC on March 17, 2021, and Boston Private commenced mailing of the definitive proxy statement/prospectus to its shareholders on or about March 19, 2021. This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. INVESTORS AND SHAREHOLDERS OF BOSTON PRIVATE ARE URGED TO READ THE REGISTRATION STATEMENT AND THE DEFINITIVE PROXY STATEMENT/PROSPECTUS REGARDING THE MERGER AND ANY OTHER RELEVANT DOCUMENTS FILED WITH THE SEC, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THOSE DOCUMENTS, BECAUSE THEY CONTAIN IMPORTANT INFORMATION.

A free copy of the definitive proxy statement/prospectus, as well as other filings containing information about SVB Financial and Boston Private, may be obtained at the SEC’s Internet site (http://www.sec.gov). Copies of documents filed with the SEC by SVB Financial will be made available free of charge on SVB Financial’s website at http://ir.svb.com or by contacting SVB Financial’s Investor Relations department at 408.654.7400; 3005 Tasman Drive, Santa Clara, CA 95054; or [email protected]. Copies of documents filed with the SEC by Boston Private will be made available free of charge on Boston Private’s website at http://ir.bostonprivate.com or by contacting Boston Private’s Investor Relations department at 617.912.4386; 10 Post Office Square, Boston, MA 02109; or [email protected].

Participants in the Solicitation

SVB Financial, Boston Private and certain of their respective directors and executive officers may be deemed to be participants in the solicitation of proxies from the shareholders of Boston Private in connection with the proposed merger. Information about the directors and executive officers of SVB Financial is set forth in the proxy statement for SVB Financial’s 2021 Annual Meeting of Stockholders, which was filed with the SEC on March 4, 2021, and other documents filed by SVB Financial with the SEC. Information about the directors and executive officers of Boston Private is set forth in Boston Private’s Form 10-K for the year ended December 31, 2020, as amended, and other documents filed by Boston Private with the SEC. Additional information regarding the interests of those participants and other persons who may be deemed participants in the transaction may be obtained by reading the definitive proxy statement/prospectus regarding the proposed merger. Free copies of this document may be obtained as described in the preceding paragraph.

_______________________

1 Bank transactions in excess of $500 million since January 1, 2018.

2 Based on equity research consensus 2021 earnings per share estimates of $0.62 per share as disclosed in Boston Private’s definitive proxy statement.

3 Bank transactions in excess of $500 million since January 1, 2018.

4 As of April 1, 2021. SVB Financial 1-year, 3-year, 5-year and 10-year total shareholder return (“TSR”) of 245%, 101%, 369% and 742%, as compared to peers’ TSR of 127%, 18%, 124% and 198% and median of the KBW Nasdaq Bank Index TSR of 114%, 21%, 105% and 181% over the same periods. Peers based on Morgan Stanley fairness opinion analysis, other than People’s United Financial, Inc., where trading has been disrupted by the announced sale to M&T Bank Corporation.

5 Based on estimated 2021 earnings per share of $20.52 per Thomson Reuters median street estimates as of March 22, 2021, following SVB Financial’s Form 8-K providing updated guidance.

6 Applying the agreed-upon pricing formula 30 trading days later would have yielded an exchange ratio of 0.0168x and a current implied value of the merger consideration of $10.22 per share, or approximately $840 million, as compared to the actual current implied value of the merger consideration of $13.12 per share, or approximately $1.08 billion, in each case based on SVB Financial’s closing price on April 1, 2021.

7 FactSet data as of March 31, 2021 for bank transactions in excess of $500 million since January 1, 2010.

Investor Relations

Adam Bromley

(617) 912-4386

[email protected]

Media

Lucy Muscarella

(617) 912-4402

[email protected]

KEYWORDS: United States North America Massachusetts

INDUSTRY KEYWORDS: Banking Professional Services Finance

MEDIA:

Logo
Logo

Pennsylvania American Water Signs Agreement to Purchase City of York Wastewater System

Pennsylvania American Water Signs Agreement to Purchase City of York Wastewater System

Company will make necessary wastewater infrastructure upgrades to improve the system serving more than 45,000 customer connections

MECHANICSBURG, Pa.–(BUSINESS WIRE)–
Pennsylvania American Water, a subsidiary of American Water (NYSE: AWK), announced today that it has signed an agreement with the York City Sewer Authority to purchase the wastewater system assets of the City of York in York County for $235 million. The City’s wastewater system directly and indirectly serves more than 45,000 connections.

“Pennsylvania American Water looks forward to becoming the wastewater provider for the City of York and surrounding communities and delivering safe, reliable service that meets or surpasses all regulations and protects the environment,” said Pennsylvania American Water President Mike Doran. “We are committed to being an excellent community partner and delivering on our infrastructure investment, technical expertise and decades of wastewater experience while providing the city with vital funding for this community for years to come.”

The agreement was approved by the York City Council on March 2 and by the York City Sewer Authority on March 24.

“With this agreement, York’s future is bright – free from the debt and financial pain that have held us back for so long,” said York Mayor Michael Helfrich, noting that the sale will provide much-needed revenues to the city, averting devastating tax increases and cuts to essential services while also retiring long-term debts. “This is a new day for York, one filled with an unwavering optimism as our residents and businesses can finally breathe a sigh of relief for the first time in decades.”

As part of the agreement, Pennsylvania American Water will request approval to preserve York City’s current wastewater rates for a minimum of three years, offer employment to all of the city’s wastewater system employees, establish an in-person customer service center in York, provide an up-front deposit of $20 million, and contribute at least $50,000 in donations to nonprofit organizations serving the city and its residents. The company will also continue to provide contracted wholesale wastewater treatment and disposal for the municipalities of Manchester Township, West Manchester Township, York Township, North York Borough, West York Borough, Spring Garden Township and Springettsbury Township and looks forward to developing strong partnerships that meet the needs of all customers, including those outside the city.

Upon ownership, Pennsylvania American Water will make necessary treatment and collection system upgrades to improve the system. Specifically, the company plans to make significant investments toward reducing inflow and infiltration and removing phosphorus, which will improve the overall water quality in Codorus Creek and, ultimately, the Chesapeake Bay Watershed.

Pennsylvania American Water will seek all necessary approvals from its regulators and expects to close the transaction by the end of 2021 or the beginning of 2022. The company’s rates are set by the Pennsylvania Public Utility Commission (PUC), and any future rate changes would have to be reviewed and approved by the PUC.

The purchase agreement between Pennsylvania American and the City was executed under Act 12, which allows municipalities to sell their water and wastewater systems for a price based on the fair market value of the facilities. Enacted in 2016, this statute gives municipalities the opportunity to receive a purchase price that is more reflective of the current value of their system assets.

In 2020, Pennsylvania American Water acquired the wastewater assets of Borough of Kane Authority in McKean County and the water assets of Winola Water Company in Wyoming County, adding approximately 2,100 new customers. The company also signed purchase agreements with Brentwood Borough in Allegheny County, Valley Township in Chester County, and Royersford Borough and Upper Pottsgrove Township in Montgomery County, which will add another 10,300 wastewater customers and 1,700 water customers to the company’s customer base upon closing. Pennsylvania American Water also has a proven track record of successfully acquiring and managing large municipal wastewater systems like York City Sewer Authority, including the Municipal Authority of the City of McKeesport in 2017 and the Scranton Sewer Authority in 2016.

About Pennsylvania American Water

Pennsylvania American Water, a subsidiary of American Water (NYSE: AWK), is the largest investor-owned water utility in the state, providing high-quality and reliable water and/or wastewater services to approximately 2.4 million people. With a history dating back to 1886, American Water is the largest and most geographically diverse U.S. publicly traded water and wastewater utility company. The company employs more than 7,000 dedicated professionals who provide regulated and market-based drinking water, wastewater and other related services to 15 million people in 46 states. American Water provides safe, clean, affordable and reliable water services to our customers to help make sure we keep their lives flowing. For more information, visit amwater.com and follow American Water on Twitter,Facebook and LinkedIn.

Cautionary Statement Concerning Forward-Looking Statements

Certain statements in this press release are forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements relate to, among other things, the completion of the proposed acquisition; the ability to satisfy closing and other conditions related to the proposed transaction, including obtaining regulatory approvals; anticipated capital investments; and the ability to achieve certain benefits, synergies and goals relating to the transaction and the operations to be acquired. These statements are based on the current expectations of management of Pennsylvania American Water. There are a number of risks and uncertainties that could cause actual results to differ materially from these forward-looking statements, including with respect to (1) obtaining the regulatory and other approvals required for the acquisition; (2) the result of the fair market value appraisal required by Act 12; (3) satisfying other conditions to the closing of the acquisition; (4) the occurrence of the benefits and synergies expected or predicted to occur as a result of the acquisition; (5) unexpected costs, liabilities or delays associated with the acquisition or the integration of the acquired business; (6) regulatory, legislative, local or municipal actions affecting the water and wastewater industries, which could adversely affect Pennsylvania American Water; and (7) other economic, business and other factors. Forward-looking statements are not guarantees or assurances of future performance or results, and Pennsylvania American Water and its affiliates do not undertake any duty to update any forward-looking statement.

Laura Martin, Director, Communications & External Affairs

304-932-7158

[email protected]

KEYWORDS: United States North America Pennsylvania

INDUSTRY KEYWORDS: Public Policy/Government State/Local Other Natural Resources Utilities Environment Natural Resources Energy

MEDIA:

Logo
Logo

Brian Thompson Named Chief Executive Officer of UnitedHealthcare Unit

Brian Thompson Named Chief Executive Officer of UnitedHealthcare Unit

MINNETONKA, Minn.–(BUSINESS WIRE)–
Brian Thompson has been named Chief Executive Officer of UnitedHealthcare, the health benefits business of UnitedHealth Group (NYSE: UNH).

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210407005251/en/

Brian Thompson has been named Chief Executive Officer of UnitedHealthcare, the health benefits business of UnitedHealth Group. (Photo: Business Wire)

Brian Thompson has been named Chief Executive Officer of UnitedHealthcare, the health benefits business of UnitedHealth Group. (Photo: Business Wire)

Thompson joined UnitedHealth Group in 2004 and most recently was CEO of UnitedHealthcare’s government programs including the Medicare & Retirement and Community & State businesses, serving the health and well-being needs of seniors and Medicaid beneficiaries. As CEO of UnitedHealthcare, Thompson will drive continued growth across the global, employer, individual, specialty and government benefits businesses while continuing the company’s focus on ensuring access to high-quality, affordable health care.

“Brian’s experience, relationships and values make him especially well-suited to help UnitedHealthcare improve how health care works for consumers, physicians, employers, governments and our other partners, leading to continued and sustained long-term growth,” said Andrew Witty, CEO of UnitedHealth Group.

About UnitedHealth Group

UnitedHealth Group (NYSE: UNH) is a diversified health care company dedicated to helping people live healthier lives and helping make the health system work better for everyone. UnitedHealth Group offers a broad spectrum of products and services through two distinct platforms: Optum, which provides information and technology-enabled health care services; and UnitedHealthcare, which provides health care coverage and benefits services. For more information, visit UnitedHealth Group at www.unitedhealthgroup.com or follow @UnitedHealthGrp on Twitter.

Eric Hausman

VP, Media Relations

612-990-7078

[email protected]

KEYWORDS: United States North America Minnesota

INDUSTRY KEYWORDS: Professional Services Health Hospitals Insurance General Health Pharmaceutical Biotechnology

MEDIA:

Logo
Logo
Photo
Photo
Brian Thompson has been named Chief Executive Officer of UnitedHealthcare, the health benefits business of UnitedHealth Group. (Photo: Business Wire)

Li-Cycle Strengthens IP Position Receiving Two Additional U.S. Patents

Li-Cycle Strengthens IP Position Receiving Two Additional U.S. Patents

Li-Cycle continues to build technology presence in United States with granted patents from the U.S. Patent and Trademark Office relating to the processing and recovery of critical, finite materials from lithium-ion batteries

TORONTO–(BUSINESS WIRE)–Li-Cycle Corp. (“Li-Cycle” or the “Company”), an industry leader in lithium-ion battery resource recovery and the largest lithium-ion battery recycler in North America, today announced that the U.S. Patent and Trademark Office (“USPTO”) has granted it two utility patents, No. 10,919,046 and No. 10,960,403, which further strengthen Li-Cycle’s IP position in the U.S. and as a technology leader.

Li-Cycle is a technology-focused business and receiving these patents demonstrates the Company’s strong technology position in the U.S. market. The Company has a robust and growing patent portfolio, with a focus on innovation, research and development, as well as continued commercialization of its proprietary battery recycling technology.

“We are very excited to announce that the USPTO has granted us two utility patents, as these mark another significant step forward for Li-Cycle and further reinforce our IP position in the North American market and in turn, globally,” said Tim Johnston, Co-Founder and Executive Chairman of Li-Cycle. “At its core, Li-Cycle is a technology company, and we will continue to innovate as the leader in sustainable processing and recovery of critical, finite materials from lithium-ion batteries to reintroduce them back into the economy and close the supply chain loop. Technology development and commercialization will continue to remain of paramount focus for our business as we scale globally.”

These recently granted patents No. 10,919,046 and No. 10,960,403, in combination with Li-Cycle’s related, pending U.S. patent publication nos. US2020/0078796, US2021/0078013, and US2021/0078012, strengthen Li-Cycle’s intellectual property position in the United States in relation to the processing and recovery of critical, finite materials from lithium-ion batteries.

The imperative for economically and environmentally sustainable resource recovery and recycling is growing in lockstep with the rapid growth of battery manufacturing. Li-Cycle utilizes its patented Spoke & Hub Technologies™ to achieve the industry-leading recovery rate and to produce the critical battery materials underpinning the global growth in electric vehicle production. Legacy recycling technologies have largely relied on thermal operations, which can emit harmful emissions and result in lower recovery rates. Li-Cycle’s Spoke & Hub Technologies™ achieve up to 95% resource mass recovery. The Company’s two-stage battery recycling model enables customers to benefit from a safe and environmentally friendly solution for recycling all types of lithium-ion battery materials.

On February 16, 2021, Li-Cycle announced its entry into a definitive business combination agreement with Peridot Acquisition Corp. (NYSE: PDAC) (“Peridot”). Upon the closing of the business combination, which is expected in the second quarter of 2021, the combined company will be named Li-Cycle Holdings Corp. Li-Cycle intends to apply to list the common shares of the combined company on the New York Stock Exchange under the new ticker symbol, “LICY.”

About Li-Cycle Corp.

Li-Cycle is on a mission to leverage its innovative Spoke & Hub Technologies™ to provide a customer-centric, end-of-life solution for lithium-ion batteries, while creating a secondary supply of critical battery materials. Lithium-ion rechargeable batteries are increasingly powering our world in automotive, energy storage, consumer electronics, and other industrial and household applications. The world needs improved technology and supply chain innovations to better manage battery manufacturing waste and end-of-life batteries and to meet the rapidly growing demand for critical and scarce battery-grade raw materials through a closed-loop solution. For more information, visit https://li-cycle.com/.

ADDITIONAL INFORMATION AND WHERE TO FIND IT

In connection with the proposed transaction involving Li-Cycle and Peridot, Li-Cycle Holdings Corp. (“Newco”) has prepared and filed with the SEC a registration statement on Form F-4 that includes both a prospectus of Newco and a proxy statement of Peridot (the “Proxy Statement/Prospectus”). Once effective, Peridot will mail the Proxy Statement/Prospectus to its shareholders and file other documents regarding the proposed transaction with the SEC. This communication is not a substitute for any proxy statement, registration statement, proxy statement/prospectus or other documents Peridot or Newco may file with the SEC in connection with the proposed transaction. INVESTORS AND SECURITY HOLDERS ARE URGED TO READ CAREFULLY AND IN THEIR ENTIRETY THE PROXY STATEMENT/PROSPECTUS WHEN IT BECOMES AVAILABLE, ANY AMENDMENTS OR SUPPLEMENTS TO THE PROXY STATEMENT/PROSPECTUS, AND OTHER DOCUMENTS FILED BY PERIDOT OR NEWCO WITH THE SEC IN CONNECTION WITH THE PROPOSED TRANSACTION BECAUSE THESE DOCUMENTS WILL CONTAIN IMPORTANT INFORMATION. Investors and security holders will be able to obtain free copies of the Proxy Statement/Prospectus and other documents filed with the SEC by Peridot or Newco through the website maintained by the SEC at www.sec.gov.

Investors and securityholders will also be able to obtain free copies of the documents filed by Peridot and/or Newco with the SEC on Peridot’s website at www.peridotspac.com or by emailing [email protected].

PARTICIPANTS IN THE SOLICITATION

Li-Cycle, Peridot, Newco, and certain of their respective directors, executive officers and employees may be deemed to be participants in the solicitation of proxies in connection with the proposed transaction. Information regarding the persons who may, under the rules of the SEC, be deemed participants in the solicitation of proxies in connection with the proposed transaction, including a description of their direct or indirect interests, by security holdings or otherwise, are set forth in the Proxy Statement/Prospectus. Information regarding the directors and executive officers of Peridot is contained in Peridot’s Annual Report on Form 10-K for the year ended December 31, 2020, filed with the SEC on March 26, 2021 and certain of its Current Reports filed on Form 8-K. These documents can be obtained free of charge from the sources indicated above.

NO OFFER OR SOLICITATION

This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities of Peridot or Newco or a solicitation of any vote or approval. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.

CAUTION CONCERNING FORWARD-LOOKING STATEMENTS

Certain statements contained in this communication may be considered forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21 of the Securities Exchange Act of 1934, as amended, including statements regarding the proposed transaction involving Li-Cycle and Peridot and the ability to consummate the proposed transaction. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as “may,” “will,” “should,” “would,” “expect,” “anticipate,” “plan,” “likely”, “believe,” “estimate,” “project,” “intend,” and other similar expressions among others. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement as a result of various factors, including, without limitation: (i) the risk that the conditions to the closing of the proposed transaction are not satisfied, including the failure to timely or at all obtain shareholder approval for the proposed transaction or the failure to timely or at all obtain any required regulatory clearances, including under the Hart-Scott Rodino Antitrust Improvements Act; (ii) uncertainties as to the timing of the consummation of the proposed transaction and the ability of each of Li-Cycle and Peridot to consummate the proposed transaction; (iii) the possibility that other anticipated benefits of the proposed transaction will not be realized, and the anticipated tax treatment of the combination; (iv) the occurrence of any event that could give rise to termination of the proposed transaction; (v) the risk that stockholder litigation in connection with the proposed transaction or other settlements or investigations may affect the timing or occurrence of the proposed transaction or result in significant costs of defense, indemnification and liability; (vi) changes in general economic and/or industry specific conditions; (vii) possible disruptions from the proposed transaction that could harm Li-Cycle’s business; (viii) the ability of Li-Cycle to retain, attract and hire key personnel; (ix) potential adverse reactions or changes to relationships with customers, employees, suppliers or other parties resulting from the announcement or completion of the proposed transaction; (x) potential business uncertainty, including changes to existing business relationships, during the pendency of the proposed transaction that could affect Li-Cycle’s financial performance; (xi) legislative, regulatory and economic developments; (xii) unpredictability and severity of catastrophic events, including, but not limited to, acts of terrorism, outbreak of war or hostilities and any epidemic, pandemic or disease outbreak (including COVID-19), as well as management’s response to any of the aforementioned factors; and (xiii) other risk factors as detailed from time to time in Peridot’s reports filed with the SEC, including Peridot’s annual report on Form 10-K, periodic quarterly reports on Form 10-Q, periodic current reports on Form 8-K and other documents filed with the SEC. The foregoing list of important factors is not exclusive. Neither Li-Cycle nor Peridot can give any assurance that the conditions to the proposed transaction will be satisfied. Except as required by applicable law, neither Li-Cycle nor Peridot undertakes any obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.

Investor Relations: [email protected]

Press: [email protected]

KEYWORDS: North America Canada

INDUSTRY KEYWORDS: Environment Hardware Alternative Energy Energy Alternative Vehicles/Fuels Automotive Consumer Electronics Technology

MEDIA:

Logo
Logo

Plymouth Industrial REIT Adds Caitlin Murphy to Board of Directors

Plymouth Industrial REIT Adds Caitlin Murphy to Board of Directors

BOSTON–(BUSINESS WIRE)–
Plymouth Industrial REIT, Inc. (NYSE: PLYM) announced it has appointed Caitlin Murphy to the Board of Directors, effective April 5, 2021. Ms. Murphy will serve as an independent director and stand for re-election at the Company’s annual stockholder meeting. This appointment increases Plymouth’s Board of Directors to eight members.

Ms. Murphy is the founder and CEO of Global Gateway Logistics based in St. Louis, Missouri. Prior to founding Global Gateway Logistics, she was Director of Business Development for Axis Worldwide Supply Chain & Logistics and was an International General Commodities Specialist for UniGroup Worldwide Logistics. Ms. Murphy began her career with IM Force in Beijing, China as an Associate, Overseas Development and Marketing. She holds a BSBA in International Business from the University of Missouri.

Jeff Witherell, Chairman and Chief Executive Officer of Plymouth, noted, “We have intentionally sought to add direct experience in logistics and supply chain operations in our largest markets to the board of directors. Caitlin has extensive experience in the logistics industry and firsthand knowledge of our industrial markets throughout the Midwest as well as the fundamentals that are driving demand for our space. We expect she will bring a valuable industry perspective that will complement the extensive real estate and investment experience that already exists on Plymouth’s board of directors.”

About Plymouth

Plymouth Industrial REIT, Inc. (NYSE: PLYM) is a real estate investment trust focused on the acquisition, ownership and management of single and multi-tenant industrial properties, including distribution centers, warehouses, light industrial and small bay industrial properties, located in primary and secondary markets within the main industrial, distribution and logistics corridors of the United States.

Forward-Looking Statements

This press release includes “forward-looking statements” that are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933 and of Section 21E of the Securities Exchange Act of 1934. The forward-looking statements in this release do not constitute guarantees of future performance. Investors are cautioned that statements in this press release, which are not strictly historical statements, including, without limitation, statements regarding management’s plans, objectives and strategies, constitute forward-looking statements. Such forward-looking statements are subject to a number of known and unknown risks and uncertainties that could cause actual results to differ materially from those anticipated by the forward-looking statement, many of which may be beyond our control. Forward-looking statements generally can be identified by the use of forward-looking terminology such as “may,” “plan,” “seek,” “will,” “expect,” “intend,” “estimate,” “anticipate,” “believe” or “continue” or the negative thereof or variations thereon or similar terminology. Any forward-looking information presented herein is made only as of the date of this press release, and we do not undertake any obligation to update or revise any forward-looking information to reflect changes in assumptions, the occurrence of unanticipated events, or otherwise.

Tripp Sullivan

SCR Partners

(615) 942-7077

[email protected]

KEYWORDS: United States North America Massachusetts

INDUSTRY KEYWORDS: Other Construction & Property Commercial Building & Real Estate Construction & Property REIT

MEDIA:

Logo
Logo

Houston County Board of Education Supports Teachers and Distance Learners with RingCentral

Houston County Board of Education Supports Teachers and Distance Learners with RingCentral

BELMONT, Calif.–(BUSINESS WIRE)–RingCentral, Inc. (NYSE:RNG), a leading provider of global enterprise cloud communications, video meetings, collaboration, and contact center solutions, today announced that Houston County Board of Education is utilizing RingCentral to create a district-wide support center for its teachers and distance learners. The Houston County School District, which educates 30,000 K-12 students across 37 campuses, uses RingCentral’s cloud-based communications solution to enable the district’s small but nimble team to categorize, manage and field enquiries from staff and students who were experiencing difficulty with their digital homeschooling set-up.

Houston County Board had to solve the same unique challenge that faced schools all over the world: how to address growing concerns from parents and students about how to deal with technical issues on top of moving to education from home. The district began receiving large volumes of technical support calls from families and teachers and realized that most calls fell into a few standard categories. These included questions about online learning platforms, challenges students were experiencing with their laptops, and login or account problems.

Fortunately, Houston County Board, who had already deployed RingCentral’s cloud-based communications solution, were able to rapidly set up a technical support center to manage incoming inquiries in under an hour.

“During the pandemic, when the county went into lockdown and we were all working remotely, it was tremendously beneficial to be able to quickly create call groups to manage common issues and get them fixed,” said Brian Trent, director of Technology for the Houston County Board of Education. “The benefits of having RingCentral went beyond our makeshift support center. The SMS text feature using the school’s numbers, meant a teacher or administrator who couldn’t take a parent’s call could still respond via SMS text.”

“We all know that 2020 was a tough year for teachers, students and parents transitioning to remote learning,” said Nat Natarajan, executive vice president of Products and Engineering at RingCentral. “It’s great to see a customer use RingCentral in an innovative way like Houston County Board has to help ease through a difficult transition.”

For more information on how Houston County Board implemented RingCentral’s solution, view the case study.

About RingCentral

RingCentral, Inc. (NYSE: RNG) is a leading provider of business cloud communications and contact center solutions based on its powerful Message Video Phone™   (MVP™) platform. More flexible and cost effective than legacy on-premise PBX and video conferencing systems that it replaces, RingCentral empowers modern mobile and distributed workforces to communicate, collaborate, and connect via any mode, any device, and any location. RingCentral offers three key products in its portfolio including RingCentral Office® , a Unified Communications as a Service (UCaaS) platform including team messaging, video meetings, and a cloud phone system, Glip ®  the company’s free video meetings solution with team messaging that enables Smart Video Meetings™, and RingCentral cloud Contact Center  solutions. RingCentral’s open platform integrates with leading third party business applications and enables customers to easily customize business workflows. RingCentral is headquartered in Belmont, California, and has offices around the world.

© 2021 RingCentral, Inc. All rights reserved. RingCentral, Message Video Phone,  MVP, RingCentral Office, Glip, Smart Video Meetings, and the RingCentral logo are trademarks of RingCentral, Inc.

Mariel Santos

[email protected]

650-830-4493

KEYWORDS: California Texas United States North America

INDUSTRY KEYWORDS: Technology Mobile/Wireless Audio/Video Training Preschool Other Education Continuing University Other Technology Primary/Secondary Telecommunications Education Networks VoIP

MEDIA:

Logo
Logo

FireEye to Announce First Quarter 2021 Financial Results on April 27, 2021

FireEye to Announce First Quarter 2021 Financial Results on April 27, 2021

MILPITAS, Calif.–(BUSINESS WIRE)–
FireEye, Inc. (NASDAQ: FEYE), the intelligence-led security company, today announced that it will release financial results for its first quarter 2021 on Tuesday, April 27, 2021 after the close of the U.S. markets. FireEye will host a conference call the same day at 5 p.m. ET (2 p.m. PT) to discuss the results.

Interested parties may access the conference call by dialing 877-312-5521 (domestic) or 678-894-3048 (international). A live audio webcast of the call may be accessed from the Investor Relations section of the company’s website at https://investors.fireeye.com. Shortly after the conclusion of the call, an archived version of the webcast will be available at the same website.

About FireEye, Inc.

FireEye is the intelligence-led security company. Working as a seamless, scalable extension of customer security operations, FireEye offers a single platform that blends innovative security technologies, nation-state grade threat intelligence, and world-renowned Mandiant® consulting. With this approach, FireEye eliminates the complexity and burden of cyber security for organizations struggling to prepare for, prevent, and respond to cyber attacks. FireEye has over 9,900 customers across 103 countries, including more than 50 percent of the Forbes Global 2000.

© 2021 FireEye, Inc. All rights reserved. FireEye and Mandiant are registered trademarks or trademarks of FireEye, Inc. in the United States and other countries. All other brands, products, or service names are or may be trademarks or service marks of their respective owners.

Investors:

[email protected]

Media:

[email protected]

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Security Technology Telecommunications Software Networks Internet Hardware

MEDIA:

Logo
Logo

Orthofix Announces Board Chair Transition

Orthofix Announces Board Chair Transition

Ron Matricaria to Conclude Service as Chairman of Orthofix Board of Directors

Catherine Burzik to be Nominated for Election at the 2021 Annual Meeting

LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and extremities focus, today announced that Ron Matricaria, Chairman of the Orthofix Board of Directors since 2014, has decided not to stand for re-election at the Company’s 2021 Annual Meeting in order to focus on other personal and business commitments. The Board will nominate Catherine Burzik for election as Chair of the Orthofix Board of Directors. Ms. Burzik has over 30 years of experience as a senior executive and board member of major medical device, diagnostic and life sciences businesses. In addition, Maria Sainz, who has served 12 cumulative years as a director, has decided not to stand for re-election at the Annual Meeting in order to focus on her own personal and business commitments, and the size of the Board will be reduced from nine to eight seats in connection with her departure as a director.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210407005270/en/

The Orthofix Board has nominated Catherine Burzik for election as the next Chair of the Orthofix Board of Directors. (Photo: Business Wire)

The Orthofix Board has nominated Catherine Burzik for election as the next Chair of the Orthofix Board of Directors. (Photo: Business Wire)

“I am honored to have led Orthofix as Chair of the Board and to have worked with so many dedicated individuals who truly care about bringing quality medical devices and solutions to the market,” said Mr. Matricaria. “When I joined the Company, my goal was to help shape it for the years to come, leaving it stronger and well-positioned for the road ahead. Orthofix has a very bright future, and I am confident that Cathy’s vast healthcare experience will provide the Orthofix Board valuable leadership and insights as the Company continues its mission to deliver innovative, quality-driven solutions to improve the lives of patients around the world.”

Ms. Burzik previously served as President and Chief Executive Officer of Kinetic Concepts, Inc., a global medical device company, from 2006 until the company’s sale in 2011. Prior to this, she served as President of Applied Biosystems Group and held senior executive positions at Eastman Kodak and Johnson & Johnson, including Chief Executive Officer and President of Kodak Health Imaging Systems and President of Ortho-Clinical Diagnostics, Inc., a Johnson & Johnson company. In 2019, Ms. Burzik received the AdvaMed Lifetime Achievement Award that honors accomplishments of pioneers in the medical technology industry whose contributions have had a significant impact on patients’ lives and the industry as an essential part of America’s economy.

Currently Ms. Burzik is a member of the Board of Directors of Becton, Dickinson and Company, where she Chairs the Quality and Regulatory Compliance Committee and serves on the Corporate Governance and Nominating Committee, and the Science, Marketing, Innovation and Technology Committees. Ms. Burzik is also a member of the Board of Directors of Haemonetics Corporation where she Chairs the Technology Committee and serves on the Audit Committee. Additionally, she serves as Executive Chairman of Gemini Bioproducts, Inc., Chairman of StemBioSys, Inc., and Chairman of the American College of Wound Healing and Tissue Repair. Ms. Burzik previously served on the Board of Directors for the San Antonio Branch of the Dallas Federal Reserve Board, Allscripts, Inc., Bausch & Lomb, Cordis Corporation and AdvaMed.

“My career has been devoted to advancing the healthcare industry and I would be honored to be a part of Orthofix,” said Ms. Burzik. “The opportunity to step into the role of Chair of the Orthofix Board of Directors is exciting given how well-positioned I believe the company is for growth. It would be very rewarding to work with such a talented group of leaders to continue to advance the progress the Company is making in the delivery of meaningful life-changing technologies.”

“I want to thank Ron and Maria for their years of dedicated service on the Orthofix Board. Their guidance has been invaluable to me and the team as we have worked to position Orthofix for the future,” said Orthofix President and Chief Executive Officer Jon Serbousek. “I look forward to welcoming Cathy as the new Chair of the Orthofix Board upon her election. Her experience across many sectors of the healthcare industry as a senior executive, board member and investor will provide great perspective as we continue building on the capabilities created in 2020 to drive growth and pursue high value solutions for patients, surgeons, and hospitals around the world.”

About Orthofix

Orthofix Medical Inc. is a global medical device and biologics company with a spine and extremities focus. The Company’s mission is to deliver innovative, quality-driven solutions as we partner with health care professionals to improve patients’ lives. Headquartered in Lewisville, Texas, Orthofix’s spine and orthopedic extremities products are distributed in more than 70 countries via the Company’s sales representatives and distributors. For more information, please visit www.Orthofix.com.

Forward-Looking Statements

This release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended, relating to our business and financial outlook, which are based on our current beliefs, assumptions, expectations, estimates, forecasts and projections. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “projects,” “intends,” “predicts,” “potential,” or “continue” or other comparable terminology. These forward-looking statements are not guarantees of our future performance and involve risks, uncertainties, estimates and assumptions that are difficult to predict, including the risks described in Part I, Item 1A under the heading Risk Factors in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020 (the “2020 Form 10-K”). As a result of these various risks, our actual outcomes and results may differ materially from those expressed in these forward-looking statements.

We discuss some of these matters more fully, as well as certain risk factors that could affect our business, financial condition, results of operations, and prospects, in reports we file from time-to-time with the SEC, which are available to read at www.sec.gov. Any or all forward-looking statements that we make may turn out to be wrong (due to inaccurate assumptions that we make or otherwise), and our actual outcomes and results may differ materially from those expressed in these forward-looking statements. You should not place undue reliance on any of these forward-looking statements. Further, any forward-looking statement speaks only as of the date hereof, unless it is specifically otherwise stated to be made as of a different date. We undertake no obligation to update, and expressly disclaim any duty to update, our forward-looking statements, whether as a result of circumstances or events that arise after the date hereof, new information, or otherwise.

Alexa Huerta

Investor Relations

Tel 214 937 3190

[email protected]

Denise Landry

Media Relations

Tel 214 937 2529

[email protected]

KEYWORDS: United States North America Texas

INDUSTRY KEYWORDS: Health Medical Devices Other Health

MEDIA:

Logo
Logo
Photo
Photo
The Orthofix Board has nominated Catherine Burzik for election as the next Chair of the Orthofix Board of Directors. (Photo: Business Wire)

PureTech to Present at Two Upcoming Investor Conferences

PureTech to Present at Two Upcoming Investor Conferences

BOSTON–(BUSINESS WIRE)–PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, today announced that members of the management team will present at the following upcoming virtual investor conferences. Webcasts of the presentations will be available at https://investors.puretechhealth.com/events-presentations.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210407005235/en/

Members of PureTech’s management team will present at The 19th Annual Virtual Needham Healthcare Conference and a Fireside Chat with Liberum. (Photo: Business Wire)

Members of PureTech’s management team will present at The 19th Annual Virtual Needham Healthcare Conference and a Fireside Chat with Liberum. (Photo: Business Wire)

The 19th Annual Virtual Needham Healthcare Conference

Presenter: George Farmer, Ph.D., Chief Financial Officer

Date: Monday, April 12th, 2021

Time: 11:45 AM EDT

PureTech Fireside Chat with Liberum

Presenters: Bharatt Chowrira, Ph.D., J.D., President and Chief of Business and Strategy; George Farmer, Ph.D., Chief Financial Officer

Date: Wednesday, April 28th, 2021

Time: 11:00 AM EDT

About PureTech Health

PureTech is a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, including intractable cancers, lymphatic and gastrointestinal diseases, central nervous system disorders and inflammatory and immunological diseases, among others. The Company has created a broad and deep pipeline through the expertise of its experienced research and development team and its extensive network of scientists, clinicians and industry leaders. This pipeline, which is being advanced both internally and through PureTech’s Founded Entities, as of the date of PureTech’s most recently filed Registration Statement on Form 20-F, was comprised of 24 therapeutics and therapeutic candidates, including two that have received FDA clearance and European marketing authorization. All of the underlying programs and platforms that resulted in this pipeline of therapeutic candidates were initially identified or discovered and then advanced by the PureTech team through key validation points based on the Company’s unique insights into the biology of the brain, immune and gut, or BIG, systems and the interface between those systems, referred to as the BIG Axis.

For more information, visit www.puretechhealth.com or connect with us on Twitter @puretechh.

Cautionary Note Regarding Forward-Looking Statements

This press release contains statements that are or may be forward-looking statements, including statements that relate to the company’s future prospects, developments, and strategies. The forward-looking statements are based on current expectations and are subject to known and unknown risks and uncertainties that could cause actual results, performance and achievements to differ materially from current expectations, including, but not limited to, our expectations regarding the potential therapeutic benefits of our product candidates and those risks and uncertainties described in the risk factors included in the regulatory filings for PureTech Health plc. These forward-looking statements are based on assumptions regarding the present and future business strategies of the company and the environment in which it will operate in the future. Each forward-looking statement speaks only as at the date of this press release. Except as required by law and regulatory requirements, neither the company nor any other party intends to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise.

Investors

Allison Mead Talbot

+1 617 651 3156

[email protected]

U.S. media

Stephanie Simon

+1 617 581 9333

[email protected]

KEYWORDS: United States North America Massachusetts

INDUSTRY KEYWORDS: Biotechnology Pharmaceutical Health

MEDIA:

Photo
Photo
Members of PureTech’s management team will present at The 19th Annual Virtual Needham Healthcare Conference and a Fireside Chat with Liberum. (Photo: Business Wire)
Logo
Logo